Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adalimumab in the treatment of immune-mediated diseases.
Lapadula G, Marchesoni A, Armuzzi A, Blandizzi C, Caporali R, Chimenti S, Cimaz R, Cimino L, Gionchetti P, Girolomoni G, Lionetti P, Marcellusi A, Mennini FS, Salvarani C. Lapadula G, et al. Among authors: mennini fs. Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):33-48. doi: 10.1177/03946320140270S103. Int J Immunopathol Pharmacol. 2014. PMID: 24774505 Free article. Review.
Regolazione del prezzo e rimborso dei farmaci: comparatori, endpoint e ruolo della costo-efficacia.
Jommi C, Apolone G, Scroccaro G, Acciai V, Addis A, Ardizzoni A, Bernardini R, Bortolami A, Brigido A, Buzzetti G, Canonico PL, Caprari F, Centanni S, Cernetti C, Cicchetti A, Corsico G, Damele F, de Braud F, Manurita S, Mennini FS, Olivi I, Parretta F, Pippo L, Pulimeno S, Riccaboni M, Rossi G, Saleri C, Sinibaldi A, Spandonaro F, Stefenoni C, Visentin E, Viale P, Zapparelli G, Popoli P. Jommi C, et al. Among authors: mennini fs. Glob Reg Health Technol Assess. 2022 Sep 28;9:99-104. doi: 10.33393/grhta.2022.2475. eCollection 2022 Jan-Dec. Glob Reg Health Technol Assess. 2022. PMID: 36628317 Free PMC article. Italian.
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in Italy.
Mennini FS, Panatto D, Marcellusi A, Cristoforoni P, De Vincenzo R, Di Capua E, Ferrandina G, Petrillo M, Sasso T, Ricci C, Trivellizzi N, Capone A, Scambia G, Gasparini R. Mennini FS, et al. Clin Ther. 2011 Aug;33(8):1084-1095.e4. doi: 10.1016/j.clinthera.2011.06.012. Epub 2011 Jul 23. Clin Ther. 2011. PMID: 21788076 Free article.
Cost of poor adherence to anti-hypertensive therapy in five European countries.
Mennini FS, Marcellusi A, von der Schulenburg JM, Gray A, Levy P, Sciattella P, Soro M, Staffiero G, Zeidler J, Maggioni A, Schmieder RE. Mennini FS, et al. Eur J Health Econ. 2015 Jan;16(1):65-72. doi: 10.1007/s10198-013-0554-4. Epub 2014 Jan 5. Eur J Health Econ. 2015. PMID: 24390212
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.
Blandizzi C, Gionchetti P, Armuzzi A, Caporali R, Chimenti S, Cimaz R, Cimino L, Lapadula G, Lionetti P, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Girolomoni G. Blandizzi C, et al. Among authors: mennini fs. Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):1-10. doi: 10.1177/03946320140270S101. Int J Immunopathol Pharmacol. 2014. PMID: 24774503 Free article. Review.
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab.
Armuzzi A, Lionetti P, Blandizzi C, Caporali R, Chimenti S, Cimino L, Gionchetti P, Girolomoni G, Lapadula G, Marchesoni A, Marcellusi A, Mennini FS, Salvarani C, Cimaz R. Armuzzi A, et al. Among authors: mennini fs. Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1 Suppl):11-32. doi: 10.1177/03946320140270S102. Int J Immunopathol Pharmacol. 2014. PMID: 24774504 Free article. Review.
126 results